NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
March 4th 2025Andrew G. Lee, MD, and Drew Carey, MD, return for this latest episode of the "NeuroOp Guru" to discuss the variable presentations of somatic mitochondrial mutations and the importance of muscle biopsy in diagnosing low heteroplasmy in mitochondrial diseases.
EnVision Summit 2025: Glaucoma with co-existing ocular co-morbidities
March 4th 2025At the EnVision Summit 2025 in San Juan, Puerto Rico, Poonam Misra, MD, and Alcina Lidder, MD, gave advice on managing glaucoma in patients with other ocular co-morbidities such as myopia and those who have undergone corneal transplantation.
Cigarette smoking linked to reduced choroidal vascularity
March 4th 2025The negative effects of smoking on ocular tissues are well known and include age-related macular degeneration (AMD), diabetic retinopathy, cataracts, contact lens-related keratitis, Graves’ ophthalmopathy ischemic optic neuropathy, and glaucoma.
AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
March 4th 2025Clinician-scientists play a vital role in advancing ophthalmology by balancing patient care with research, leveraging clinical insights to drive impactful discoveries, and collaborating across disciplines to stay at the forefront of innovation.
Eye-opening effects resulting from modified transconjunctival lower blepharoplasty
March 2nd 2025The aim of the study was to assess the effect of a modified TCLB procedure that added deframing and decompression maneuvers to the LOFC and its support structures to obtain better results for both the lower and upper lids.
AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
March 1st 2025The research analyzed the 1-year outcomes of 132 eyes, evaluating mean IOP, baseline changes, medication reduction, and stratifying the results by race (African American vs Caucasian) and glaucoma severity (mild, moderate, severe).
AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
February 28th 2025Emerging technologies, such as remote tonometry and genetic risk scoring, are revolutionizing glaucoma care by enabling earlier detection, personalized management, and more efficient use of resources.
AGS 2025: Long-term efficacy and safety of standalone and phaco ELT with Marc Toeteberg-Harms, MD
February 27th 2025A systematic review and meta-analysis highlights the safety and efficacy of excimer laser trabeculostomy as an implant-free MIGS procedure for managing open-angle glaucoma and ocular hypertension, either alone or in combination with cataract surgery.